Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07035093

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Led by Eli Lilly and Company · Updated on 2026-05-20

586

Participants Needed

40

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness and safety of retatrutide in easing chronic low back pain in adults who are overweight or have obesity. This phase 3 study is designed as a randomized, double-blind, placebo-controlled trial sponsored by Eli Lilly and Company. The trial aims to measure changes in pain intensity and body weight over time to better understand retatrutide's impact in this group. Participants will be randomly assigned to receive either retatrutide or a placebo, both given as injections under the skin once weekly. The study lasts about 80 weeks, with assessments occurring up to 72 weeks from the baseline. The trial focuses on evaluating pain relief and weight changes, comparing the study drug to placebo under controlled conditions. Throughout the study, participants will undergo various assessments including pain intensity ratings, body weight measurements, and evaluations of physical function, sleep, and health-related quality of life using patient-reported questionnaires. Blood tests will monitor biomarkers of inflammation, blood pressure, glycemic control, cholesterol levels, and kidney function. The research team will track these outcomes regularly to assess safety and treatment effects over the nearly two-year participation period.

CONDITIONS

Brief Title

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a history of axial-predominant low back pain
  • Have pain restricted to the low back or with referral limited to the proximal legs
  • Have a body mass index (BMI) of 27 kg/m2 or higher at screening
  • Have a history of at least one unsuccessful attempt to lose body weight through diet
Not Eligible

You will not qualify if you...

  • Have low back pain from a non-axial origin
  • Had botulinum or steroid injections to the spine within 1 year before screening
  • Had trigger point injections to the spine within 6 months before screening
  • Experienced a body weight change greater than 5 kilograms within 90 days before screening
  • Have taken drugs to promote weight loss, including over-the-counter medications, within 90 days before screening
  • Have had prior or planned surgical treatment for obesity
  • Have Type 1 Diabetes, Type 2 Diabetes, or any other form of diabetes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 72 weeks

Participants receive Retatrutide or placebo by subcutaneous injection once weekly to treat obesity or overweight and chronic low back pain.

Weekly visits for up to 72 weeks

Trial Site Locations

Total: 40 locations

1

MD First Research - Chandler

Chandler, Arizona, United States, 85286

Actively Recruiting

2

Tucson Orthopaedic Institute - North Wyatt Drive

Tucson, Arizona, United States, 85712

Actively Recruiting

3

Ark Clinical Research - Fountain Valley

Fountain Valley, California, United States, 92708

Actively Recruiting

4

St Joseph Heritage Healthcare

Fullerton, California, United States, 92835

Actively Recruiting

5

Clinical Research Institute

Los Angeles, California, United States, 90048

Actively Recruiting

6

Artemis Institute for Clinical Research

San Diego, California, United States, 92123

Actively Recruiting

7

Alpine Clinical Research Center

Boulder, Colorado, United States, 80301

Actively Recruiting

8

K2 Medical Research - Daytona Beach

Daytona Beach, Florida, United States, 32114

Actively Recruiting

9

Flourish Research - Miami, LLC

Miami, Florida, United States, 33135

Actively Recruiting

10

IMA Clinical Research St. Petersburg

St. Petersburg, Florida, United States, 33704

Actively Recruiting

11

Care Access - Tampa

Tampa, Florida, United States, 33625

Actively Recruiting

12

Charter Research - Lady Lake

The Villages, Florida, United States, 32162

Actively Recruiting

13

Conquest Research

Winter Park, Florida, United States, 32789

Actively Recruiting

14

Cotton O'Neil Clinical Research Center

Topeka, Kansas, United States, 66606

Actively Recruiting

15

Care Access - Lake Charles (Bayou Pines)

Lake Charles, Louisiana, United States, 70601

Actively Recruiting

16

MedVadis Research Corporation

Waltham, Massachusetts, United States, 02451

Actively Recruiting

17

Great Lakes Research Group, Inc.

Bay City, Michigan, United States, 48706

Actively Recruiting

18

Clinvest Headlands Llc

Springfield, Missouri, United States, 65807

Actively Recruiting

19

Center for Clinical Research

Winston-Salem, North Carolina, United States, 27103

Actively Recruiting

20

Altoona Center For Clinical Research

Duncansville, Pennsylvania, United States, 16635

Actively Recruiting

21

New Phase Research and Development

Knoxville, Tennessee, United States, 37909

Actively Recruiting

22

FutureSearch Trials of Neurology

Austin, Texas, United States, 78731

Actively Recruiting

23

Mercy Family Clinic

Dallas, Texas, United States, 75208

Actively Recruiting

24

Houston Research Institute

Houston, Texas, United States, 77079

Actively Recruiting

25

Sovah Clinical Research-River District

Danville, Virginia, United States, 24541

Actively Recruiting

26

Investigaciones Medicas Imoba Srl

Buenos Aires, Argentina, C1056ABH

Actively Recruiting

27

CIPREC

Buenos Aires, Argentina, C1061AAS

Actively Recruiting

28

Centro Médico Viamonte

Buenos Aires, Argentina, C1120AAC

Actively Recruiting

29

Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada

Buenos Aires, Argentina, C1425AGC

Actively Recruiting

30

Fundación Respirar

Buenos Aires, Argentina, C1426ABP

Actively Recruiting

31

Centro de Investigaciones Clínicas Baigorria

Granadero Baigorria, Argentina, 2152

Actively Recruiting

32

Centro Rosarino de Investigaciones Clinicas (CRICs)

Rosario, Argentina, 2000

Actively Recruiting

33

Instituto Médico Catamarca IMEC

Rosario, Argentina, 2000

Actively Recruiting

34

Centro de Diagnóstico y Rehabilitación (CEDIR)

Santa Fe, Argentina, 3000

Actively Recruiting

35

Aggarwal and Associates Limited

Brampton, Canada, L6T 0G1

Actively Recruiting

36

Winterberry Research Inc.

Hamilton, Canada, L8J 0B6

Actively Recruiting

37

Bluewater Clinical Research Group Inc.

Sarnia, Canada, N7T 4X3

Actively Recruiting

38

Care Access - Cape Breton

Sydney, Canada, B1M 0A1

Actively Recruiting

39

Dr. Anil K. Gupta Medicine Professional Corporation

Toronto, Canada, M9V 4B4

Actively Recruiting

40

Podlaskie Centrum Psychogeriatrii

Bialystok, Poland, 15-756

Completed

Loading map...

Research Team

T

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

P

Physicians interested in becoming principal investigators please contact

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Bilingual Virtually-based Intervention (PEDALL) for the Pr...

Acute Lymphoblastic Leukemia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here